WMT

129.94

-1.41%↓

COST

1,008.69

-0.25%↓

PEP

155.02

-0.37%↓

TGT

128.68

-0.85%↓

KR

67.02

-2.36%↓

WMT

129.94

-1.41%↓

COST

1,008.69

-0.25%↓

PEP

155.02

-0.37%↓

TGT

128.68

-0.85%↓

KR

67.02

-2.36%↓

WMT

129.94

-1.41%↓

COST

1,008.69

-0.25%↓

PEP

155.02

-0.37%↓

TGT

128.68

-0.85%↓

KR

67.02

-2.36%↓

WMT

129.94

-1.41%↓

COST

1,008.69

-0.25%↓

PEP

155.02

-0.37%↓

TGT

128.68

-0.85%↓

KR

67.02

-2.36%↓

WMT

129.94

-1.41%↓

COST

1,008.69

-0.25%↓

PEP

155.02

-0.37%↓

TGT

128.68

-0.85%↓

KR

67.02

-2.36%↓

Search

USANA Health Sciences Inc

Открыт

19.26 -0.21

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

18.91

Макс.

19.45

Ключевые показатели

By Trading Economics

Доход

5.1M

-1.6M

Продажи

13M

226M

P/E

Средняя по отрасли

35.586

29.378

Рентабельность продаж

-0.705

Сотрудники

1,570

EBITDA

16M

28M

Дивиденды

By Dow Jones

Следующий отчет о доходах

5 мая 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-1.1M

381M

Предыдущая цена открытия

19.47

Предыдущая цена закрытия

19.26

Техническая оценка

By Trading Central

Уверенность

Weak Bullish Evidence

USANA Health Sciences Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

24 апр. 2026 г., 00:00 UTC

Отчет

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 апр. 2026 г., 00:00 UTC

Отчет

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 апр. 2026 г., 23:47 UTC

Обсуждения рынка

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 апр. 2026 г., 23:43 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

23 апр. 2026 г., 23:43 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

23 апр. 2026 г., 23:43 UTC

Обсуждения рынка

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 апр. 2026 г., 23:13 UTC

Приобретения, слияния, поглощения

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 апр. 2026 г., 22:33 UTC

Отчет

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 апр. 2026 г., 22:17 UTC

Отчет

PLS Executed Offtake Agreement With Ronbay

23 апр. 2026 г., 22:17 UTC

Отчет

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 апр. 2026 г., 22:16 UTC

Отчет

PLS Commences Commissioning of Midstream Demonstration Plant

23 апр. 2026 г., 22:15 UTC

Отчет

PLS Group Reaffirms FY26 Guidance for All Metrics

23 апр. 2026 г., 22:14 UTC

Отчет

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 апр. 2026 г., 22:14 UTC

Отчет

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 апр. 2026 г., 22:13 UTC

Отчет

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 апр. 2026 г., 22:12 UTC

Отчет

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 апр. 2026 г., 22:12 UTC

Отчет

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 апр. 2026 г., 22:11 UTC

Отчет

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 апр. 2026 г., 22:10 UTC

Отчет

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 апр. 2026 г., 22:09 UTC

Отчет

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 апр. 2026 г., 22:08 UTC

Отчет

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 апр. 2026 г., 22:04 UTC

Отчет

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 апр. 2026 г., 21:56 UTC

Обсуждения рынка
Отчет

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 апр. 2026 г., 21:48 UTC

Приобретения, слияния, поглощения

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 апр. 2026 г., 21:27 UTC

Отчет

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 апр. 2026 г., 21:25 UTC

Отчет

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 апр. 2026 г., 21:24 UTC

Отчет

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 апр. 2026 г., 21:24 UTC

Отчет

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 апр. 2026 г., 21:21 UTC

Отчет

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 апр. 2026 г., 21:21 UTC

Отчет

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Сравнение c конкурентами

Изменение цены

USANA Health Sciences Inc Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

0

Покупка

0

Удержание

0

Продажа

Техническая оценка

By Trading Central

28.405 / 29.84Поддержка и Сопротивление

Краткосрочная

Weak Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

No Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat